Dernière mise à jour :
20/02/2026
Stabilité et compatibilité des médicaments

Bienvenue dans Stabilis.
Si vous désirez recevoir la newsletter trimestrielle, indiquez votre adresse email.

Inscrivez-vous

Pour toute question ou remarque, contactez : infostab@stabilis.org

Base de données  
Références bibliographiques : 2990
Molécules : 886
Classes pharmacologiques : 46
Stabilités en solution : 7863
Stabilités en mélange : 1469
Compatibilités : 15113
Noms commerciaux : 4581
Nouveautés - Molécules  
Antibiotique injectable Cefepime enmetazobactam 26/01/2026
Antibiotique Solution buvable Amoxicilline 16/12/2025
Anesthésique général injectable Cipepofol 12/12/2025
Antiinflammatoire injectable Ibuprofen arginine 09/10/2025
Antiinflammatoire Forme dermique Fluocinolone 06/09/2025
Antibiotique injectable Aztreonam / Avibactam 11/08/2025
Anticancéreux injectable Elranatamab 10/06/2025
Divers Forme dermique Azelaique acide 29/05/2025
Antiinflammatoire Forme dermique Hydrocortisone 29/05/2025
Diurétique Forme dermique Spironolactone 28/05/2025
Hormone Forme dermique Melatonine 27/05/2025
Antibiotique Forme dermique Metronidazole 27/05/2025
Divers Forme dermique Finasteride 13/05/2025
Divers Solution buvable Dextrose 13/05/2025
Antibiotique Gélule Amoxicilline 05/04/2025
Anticancéreux injectable Glofitamab 16/03/2025
Anticancéreux injectable Tafasitamab 16/03/2025
Anticancéreux injectable Teclistamab 16/03/2025
Anticancéreux injectable Cemiplimab 16/03/2025
Anticancéreux injectable Tremelimumab 16/03/2025
Nouveautés - Références bibliographiques  
Date de saisie
5162 Stabilité de la doxorubicine à 20 mg/mL dans des seringues en polycarbonate pour les chimioembolisations lipiodolées ou avec particules biodégradables. SFPO Congress 2025 27/01/2026
5153 Cefepime/enmetazobactam : Physicochemical stability of a novel β-Lactam/β-Lactamase Inhibitor Combination in Syringes and Elastomeric Devices. Antibiotics 26/01/2026
5156 Stability of dexmedetomidine, ketamine and lidocaine combined injectable solution for analgesia EJHP 26/01/2026
5157 Stability study of topotecan in ophthalmic prefilled syringes for intravitreal delivery EJHP 26/01/2026
5148 Stability Study of Vancomycin Dose 1 (0.5 g/100 mL) and Dose 2 (2 g/240 mL) in Easyflow Elastomeric Infusion Pump of Adria Med SRL. Report Biofordrug 19/07/2021 21/01/2026
5149 Stability Study of Cefazolin 6g/240 mL at 25°C and 32°C in Easyflow Elastomeric Infusion Pump two days - 5 mL/h by of Adriamed Medical Devices. Report Biofordrug 26/2023 21/01/2026
5150 Stability Study of Cefotaxime Dose 1 (1 g/100 mL) and Dose 2 (2 g/100 mL) in Easyflow Elastomeric Infusion Pump of Adria Med SRL. Report Biofordrug 23/06/2021 21/01/2026
5151 Stability study of NEFOPAN Dose 1 (20 mg/100 mL) and Dose 2 (40 mg/50 mL) Easyflow Elastomeric Infusion Pump of Adria Med SRL. Report Biofordrug 02/03/2022 21/01/2026
5138 Bracketed Stability Evaluation of Topical Minoxidil and Finasteride in Foamil®. Int J Pharm Compound 17/12/2025
5142 Physical Compatibility of Ertapenem and Meropenem in 0.45% Normal Saline and Plasma-Lyte A. Int J Pharm Compound 17/12/2025
5130 Etude de stabilité du bevacizumab biosimilaire (Aybintio) dilué dans du NaCl 0,9% de façon manuelle et semi-automatisée et conservé entre 2 et 8°C à l'abri de la lumière. SFPO Congress, 15-17 October 2025, Saint-Malo, Fra 08/12/2025
5132 Evaluation of in-use physicochemical stability of diluted isatuximab (ISA). Gerpac Congress, 1-3 October 2025, Hyères, France 08/12/2025
5134 Stability of vancomycin 10, 25 and 50 mg/mL ophtalmic drops in tears naturale II stored in low density polyethylene dropper bottles at 4 and 25°C for 30 days Sunnybrook Health care Center. 2025. 08/12/2025
5135 Stability of Amoxicillin 50 mg/mL Suspension in Oral Mix/Oral Syrup or Ora-Sweet/Ora-Plus in Plastic Oral Syringes and Plastic Amber Bottles at 4°C and 25°C. Sunnybrook Health care Center. 2025. 08/12/2025
5123 Stability and compatibility of oxaliplatin and generic medical partners Inc.'s leucovorin formulation. 05/12/2025
5125 Stability of ketamine 2 and 10 mg/mL diluted in 0.9% sodium chloride and stored in polypropylene syringes for 90 days at 4 and 25°C. Sunnybrook Health care Center 05/12/2025
5129 Evaluation de la stabilité physico-chimique de solutions diluées d'obinutuzumab (Gazyvaro®) à 0,4 mg/mL et 4 mg/mL : une étude sur 28 jours. SFPO Congress, 15-17 October 2025, Saint-Malo, Fra 05/12/2025
5116 Nitroglycerin Adsorption to Polyvinylchloride Seriously Interferes with Its Clinical Use. Anesth Analg 27/11/2025
5119 Stability Studies of Clonazepam 2.5 mg/mL Oral Solution and 1 mg/mL Parenteral Solution in Pre-Filled Polypropylene Syringes. Pharmaceutics 27/11/2025
5120 Analysis of the Stability of Compounded Vancomycin Hydrochloride Oral Solution: A Comparison Between Formulations Prepared Using a Commercial Product and Using the Pure Active Ingredient. Cureus 27/11/2025
5110 Stability Study of Lorazepam Oral Solution Repackaged in Amber Colored ENFit Oral Syringes. J Pediatr Pharmacol Ther 10/11/2025
5100 Local Anesthetics Adsorbed onto Infusion Balloon. Anesth Analg 01/10/2025
5095 Compatibility and Physico-Chemical Stability of Six Intravenous Mixtures for Postoperative Multimodal Analgesia. Drug Design Dev Ther 23/09/2025
5096 Compatibility and Stability of Cipepofol (Ciprofol) and Etomidate Mixture for Intravenous Anesthesia. Current Ther Res 23/09/2025
5097 Stability and physical compatibility of parenteral nalbuphine hydrochloride during continuous infusion in pediatrics. PlosOne 23/09/2025
5098 Stability of Ceftobiprole Medocaril in Portable Elastomeric Infusion Devices. Infect Dis Ther 23/09/2025
5094 SEROPRAM 20 mg/0,5 ml, solution à diluer pour perfusion - Résumé des caractéristiques du produit. LUNDBECK SAS 09/09/2025
5088 Ampicillin 500 mg powder for solution for injection - Summary of Product Characteristics Updated 04-Feb-2025 | Chemidex Pharma Ltd Chemidex Pharma Limited 05/09/2025
5089 Ascorbic Acid Injection 500mg/5ml - Summary of Product Characteristics Updated 04-Jan-2024 | Phoenix Labs Phoenix Labs 05/09/2025
5090 TILDIEM 25 mg, poudre et solution pour préparation injectable I.V. - Résumé des caractéristiques du produit. Sanofi 05/09/2025

  Mentions Légales